Dr. Veerapol Khemarangsan, M.D., Chief Executive Officer of MEDEZE Group Public Company Limited (SET:...
MEDEZE Pushes Innovation and Sustainability, Securing THB54 Million Net Profit in 2Q25
Medeze Group Public Company Limited (SET: MEDEZE) has announced 2Q25 consolidated financial statement through...
MEDEZE Celebrates 15th Anniversary, Driving Thailand Health Economy with Stem Cell Technology
Dr. Veerapol Khemarangsan, Chief Executive Officer of MEDEZE Group Public Company Limited (SET: MEDEZE),...
Medeze Terminates Partial Offer for Cordlife Group
Medeze Group Public Company Limited (SET: MEDEZE) has announced that Medeze Treasury Pte. Ltd....
KSS Recommends MEDEZE, NKT, OKJ, and TMAN from FTSE Micro-Cap Index Inclusion
In its June 2025 update, the FTSE All World Index revealed important shifts that...
Broker Prices MEDEZE at THB8.60 as Trend for Stem Cell Boost Growth Outlook
Analysts at Daol Securities (Thailand) maintain a "Buy" recommendation for MEDEZE Group Plc. (SET:...